Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magnetic zaps to the brain aim to restore arm movement in stroke survivors

NCT ID NCT05535504

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a magnetic device (rTMS) placed on the scalp could help people who had a stroke regain movement in their arm. The trial planned to include 60 adults with recent ischemic stroke. However, the study was terminated early, so the results are not complete.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
repetitive transcranial magnetic stimulation (rTMS) device
What this could lead to
If it had worked, this could point toward a non-invasive way to improve arm function after a stroke.
What could go wrong
The trial was terminated early, so we don't have clear evidence it works. It was also a small study with only 60 participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2023

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 19-80 years old * Radiologically confirmed ischemic stroke with subcortical and brainstem lesions within 90 days * Fugl-Meyer assessment scale (upper extremity) \> 15 * Mini-mental status exam (the Korean version) \> 14 with appropriate cognitive function * Written informed consent Exclusion Criteria: * Fugl-Meyer assessment scale (wrist) \< 1 or Fugl-Meyer assessment scale (hand) \< 1 * Hemorrhagic stroke or traumatic brain injury * Cerebellar stroke * Previous history of stroke * Traumatic brain injury * Previous history of brain surgery * Need for intensive care due to complications associated with stroke (e.g. pneumonia, infection, hemodynamic instability) * History of psychological or neurological diseases * History of pain or muscular weakness of upper limbs which may interfere with rehabilitation * History of seizure or epilepsy * Aphasia * Skin lesions in the stimulation site of scalp * Intracranial metal implant * Inability to receive regular physical or occupational therapy * Disagreement to use contraception in women of childbearing age

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brainstem ischemic stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Rehabilitation Medicine, Chungnam National University Hospital, Korea

    Daejeon, 35015, South Korea

  • Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital

    Seongnam-si, Korea, Gyeonggi-do, 463-707, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.